With ongoing clinical trials and promising early data, tegoprubart may soon redefine the standard of care in transplantation ...

After more than a decade of digital transformation, pharmaceutical marketing is on the cusp of achieving what the industry ...

LEAP TA: Life Sciences is the only event entirely dedicated to transforming how biotech and pharma organizations are ...

The 9th MASH Drug Development Summit is the essential forum for pharmaceutical giants and innovative biotechs dedicated to ...

Insmed has claimed the distinction of becoming the first company to get FDA approval for a treatment for chronic lung disease ...

The team, led by Dr Phillip Jenkins, a postdoctoral fellow in clinical informatics at Oregon Health & Science University, ...

In the EV-303/KEYNOTE-905 study, the combination of nectin-4-directed antibody-drug conjugate (ADC) Padcev (enfortumab ...

At Axtria Ignite 2025 in Princeton, New Jersey, editor-in-chief Jonah Comstock connected with GSK's SVP of enterprise AI and chief digital and technology officer, commercial, Madhavi Ramakrishna.

PureTech Health has launched a subsidiary company – Celea Therapeutics – with the task of taking an experimental drug for ...

Yantai-based RemeGen said it will now move ahead with filing telitacicept with China's National Medical Products Administration (NMPA), which has already approved the drug as a treatment for ...

The deal – which has a total value of up to $1.3 billion including an unspecified upfront payment – gives Bayer exclusive ...

Haematological cancers are a recognised potential side effect with Skysona and were already mentioned in a boxed warning on ...